Trust Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Sell |
8,184
-2,631
| -24% | -$308K | 0.09% | 67 |
|
|
2026
Q1 | $1.3M | Sell |
10,815
-15,997
| -60% | -$1.85M | 0.12% | 67 |
|
|
2025
Q4 | $2.82M | Sell |
26,812
-101
| -0.4% | -$9.48K | 0.26% | 42 |
|
|
2025
Q3 | $2.26M | Buy |
26,913
+1,151
| +4% | +$94.8K | 0.23% | 44 |
|
|
2025
Q2 | $2.04M | Buy |
25,762
+10,019
| +64% | +$796K | 0.23% | 44 |
|
|
2025
Q1 | $1.41M | Buy |
15,743
+4,518
| +40% | +$422K | 0.17% | 50 |
|
|
2024
Q4 | $1.12M | Buy |
11,225
+8,955
| +394% | +$923K | 0.13% | 57 |
|
|
2024
Q3 | $258K | Sell |
2,270
-48
| -2% | -$5.7K | 0.03% | 121 |
|
|
2024
Q2 | $287K | Hold |
2,318
| – | – | 0.04% | 111 |
|
|
2024
Q1 | $306K | Sell |
2,318
-333
| -13% | -$41K | 0.04% | 106 |
|
|
2023
Q4 | $289K | Sell |
2,651
-1,026
| -28% | -$107K | 0.04% | 113 |
|
|
2023
Q3 | $379K | Sell |
3,677
-3,313
| -47% | -$357K | 0.06% | 95 |
|
|
2023
Q2 | $807K | Sell |
6,990
-3,145
| -31% | -$357K | 0.12% | 59 |
|
|
2023
Q1 | $1.08M | Sell |
10,135
-2,088
| -17% | -$225K | 0.16% | 55 |
|
|
2022
Q4 | $1.36M | Sell |
12,223
-851
| -7% | -$87K | 0.22% | 44 |
|
|
2022
Q3 | $1.13M | Buy |
13,074
+4,095
| +46% | +$366K | 0.25% | 41 |
|
|
2022
Q2 | $819K | Sell |
8,979
-11,053
| -55% | -$980K | 0.18% | 58 |
|
|
2022
Q1 | $1.64M | Buy |
20,032
+236
| +1% | +$18.6K | 0.32% | 32 |
|
|
2021
Q4 | $1.52M | Sell |
19,796
-533
| -3% | -$42.5K | 0.35% | 31 |
|
|
2021
Q3 | $1.53M | Buy |
20,329
+558
| +3% | +$42.4K | 0.39% | 27 |
|
|
2021
Q2 | $1.54M | Sell |
19,771
-936
| -5% | -$69.6K | 1.08% | 22 |
|
|
2021
Q1 | $1.52M | Buy |
20,707
+7,657
| +59% | +$565K | 1.1% | 24 |
|
|
2020
Q4 | $1.02M | Buy |
13,050
+913
| +8% | +$69.8K | 0.81% | 37 |
|
|
2020
Q3 | $961K | Buy |
12,137
+1,088
| +10% | +$85.2K | 0.81% | 35 |
|
|
2020
Q2 | $815K | Buy |
11,049
+8,455
| +326% | +$637K | 0.77% | 39 |
|
|
2020
Q1 | $190K | Hold |
2,594
| – | – | 0.21% | 71 |
|
|
2019
Q4 | $225K | Sell |
2,594
-4,124
| -61% | -$339K | 0.2% | 83 |
|
|
2019
Q3 | $540K | Buy |
6,718
+151
| +2% | +$12.1K | 0.51% | 51 |
|
|
2019
Q2 | $525K | Hold |
6,567
| – | – | 0.48% | 56 |
|
|
2019
Q1 | $521K | Hold |
6,567
| – | – | 0.3% | 63 |
|
|
2018
Q4 | $479K | Buy |
6,567
+1,939
| +42% | +$137K | 0.27% | 55 |
|
|
2018
Q3 | $313K | Sell |
4,628
-800
| -15% | -$51K | 0.14% | 63 |
|
|
2018
Q2 | $314K | Hold |
5,428
| – | – | 0.14% | 65 |
|
|
2018
Q1 | $282K | Hold |
5,428
| – | – | 0.1% | 72 |
|
|
2017
Q4 | $291K | Sell |
5,428
-123,036
| -96% | -$6.82M | 0.12% | 61 |
|
|
2017
Q3 | $7.85M | Buy |
128,464
+2,106
| +2% | +$128K | 4.32% | 7 |
|
|
2017
Q2 | $7.73M | Buy |
126,358
+17,826
| +16% | +$1.09M | 3.57% | 4 |
|
|
2017
Q1 | $6.58M | Buy |
108,532
+10,739
| +11% | +$652K | 2.99% | 5 |
|
|
2016
Q4 | $5.49M | Buy |
97,793
+11,208
| +13% | +$656K | 2.79% | 8 |
|
|
2016
Q3 | $5.16M | Buy |
86,585
+81,200
| +1,508% | +$4.75M | 2.26% | 7 |
|
|
2016
Q2 | $296K | Hold |
5,385
| – | – | 0.11% | 88 |
|
|
2016
Q1 | $272K | Sell |
5,385
-157
| -3% | -$7.69K | 0.12% | 92 |
|
|
2015
Q4 | $279K | Sell |
5,542
-608
| -10% | -$30.7K | 0.13% | 80 |
|
|
2015
Q3 | $290K | Buy |
6,150
+215
| +4% | +$11.4K | 0.16% | 76 |
|
|
2015
Q2 | $322K | Buy |
5,935
+596
| +11% | +$33.4K | 0.2% | 90 |
|
|
2015
Q1 | $293K | Buy |
+5,339
| New | +$302K | 0.19% | 94 |
|
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Trust Company's MRK Position: Q2 2026 in Review
Trust Company reduced its Merck (MRK) stake by 24% in Q2 2026, selling an estimated $308K and leaving 8,184 shares worth $1.05M. The position accounts for 0.09% of the portfolio, ranked #67.
Trust Company first reported a position in MRK in Q1 2015 and has held it in 46 quarters since. The position peaked at $7.85M in Q3 2017. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Trust Company held 8,184 shares of Merck worth $1.05M as of Q2 2026.
- Trust Company sold 2,631 Merck shares in Q2 2026, an estimated $308K.
- Merck made up 0.09% of Trust Company's portfolio in Q2 2026, its #67 holding.
- Trust Company first reported a position in Merck in Q1 2015 and has held it in 46 quarters since.
- Trust Company's Merck position peaked at $7.85M in Q3 2017.
- 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.